Ophthalmic Education:
Principles and Guidelines of a Curriculum for Education of the Ophthalmic Specialist: Appendix 1: Ocular Hypertension Treatment Study (OHTS)
More on Ophthalmic Education:
Educational Resources:
ICO Educational Programs:
- Overview of ICO Education
- Resident and Specialist Education
- Ophthalmic Continuing Education
- ICO Continuing Education Requirements
- Medical Student Education
- Allied Ophthalmic Personnel Training
- World Ophthalmology Congress
- ICO Examinations
- ICO International Fellowship
- ICO International Clinical Guidelines
On this page:
Recommended Reading
Kass MA, Heuer DK, Higginbotham EJ et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002; 120: 701-713; discussion 829-830
Palmberg P. Answers from the ocular hypertension treatment study. Arch Ophthalmol 2002; 120: 829-830
Additional Background Reading
Gordon MO, Beiser JA, Brandt JD et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 2002; 120: 714-720; discussion 829-830
Keltner JL, Johnson CA, Quigg JM et al. Confirmation of visual field abnormalities in the Ocular Hypertension Treatment Study. Ocular Hypertension Treatment Study Group. Arch Ophthalmol 2000; 118: 1187-1194
Kass MA. The Ocular Hypertension Treatment Study. J Glaucoma 1994; 3: 97-100
Next: Appendix 1: Glaucoma Laser Trial (GLT) and Glaucoma Laser Trial Follow-up Study (GLTFS)
Also see: Table of Contents of the Principles and Guidelines of a Curriculum for Education of the Ophthalmic Specialist
You are here: Home > Ophthalmic Education > Resident and Specialist Education > Principles and Guidelines of a Curriculum for Education of the Ophthalmic Specialist > Appendix 1: Ocular Hypertension Treatment Study (OHTS)